Post by M. Hawbaker on Aug 2, 2021 2:23:53 GMT
Pfizer, Inc. and Moderna, Inc. which have already minted billions of dollars from their respective COVID-19 vaccines, remain poised to earn more.
What Happened: Pfizer and Moderna have both renegotiated their vaccine supply contract with the European Union, the FT reported Sunday.
The contract terms for the supply of up to 2.1 billion vaccine shots were revised after the release of the Phase 3 data, the report said. Late-stage study of the mRNA vaccine Pfizer is co-developing with BioNTech showed vaccine efficacy of 95%, while a similar class of vaccine developed by Moderna boasted vaccine efficacy of 94.1%.
The FT report states that Pfizer has increased the price of its vaccine from the originally contracted amount of 15.50 euros ($18.39) to 19.50 euros per dose. The Moderna shot price has been increased from $22.60 to $25.50.
www.benzinga.com/general/biotech/21/08/22266730/pfizer-moderna-hike-prices-of-vaccine-shots-supplied-to-eu-report
What Happened: Pfizer and Moderna have both renegotiated their vaccine supply contract with the European Union, the FT reported Sunday.
The contract terms for the supply of up to 2.1 billion vaccine shots were revised after the release of the Phase 3 data, the report said. Late-stage study of the mRNA vaccine Pfizer is co-developing with BioNTech showed vaccine efficacy of 95%, while a similar class of vaccine developed by Moderna boasted vaccine efficacy of 94.1%.
The FT report states that Pfizer has increased the price of its vaccine from the originally contracted amount of 15.50 euros ($18.39) to 19.50 euros per dose. The Moderna shot price has been increased from $22.60 to $25.50.
www.benzinga.com/general/biotech/21/08/22266730/pfizer-moderna-hike-prices-of-vaccine-shots-supplied-to-eu-report
